Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA a Cancer J Clin. 71(3):209–249
Ribeiro FE, Tebar WR, Ferrari G, Palma MR, Fregonesi CE, Caldeira DT et al (2023) Comparison of Quality of Life in Breast Cancer Survivors with and without Persistent Depressive Symptoms: a 12-month follow-up study. Int J Environ Res Public Health 20(4):3663
Article PubMed PubMed Central Google Scholar
Shabangu N, Thebe T, Casey M, Wesselmann U, Parker R (2023) Chronic pain in female breast cancer survivors-prevalence, characteristics and contributing factors: a cross-sectional pilot study. BMC Women’s Health 23(1):613
Article PubMed PubMed Central Google Scholar
Leysen L, Beckwée D, Nijs J, Pas R, Bilterys T, Vermeir S et al (2017) Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis. Support Care Cancer 25(12):3607–3643
Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ (2007) Chronic pain in the cancer survivor: a new frontier. Pain Med 8(2):189–198
Pérez C, Ochoa D, Sánchez N, Ballesteros AI, Santidrián S, López I et al (2024) Pain in long-term cancer survivors: prevalence and impact in a cohort composed mostly of breast cancer survivors. Cancers 16(8):1581
Article PubMed PubMed Central Google Scholar
Yin M, Wang C, Gu K, Bao P, Shu X-O (2023) Chronic pain and its correlates among long-term breast cancer survivors. J Cancer Surviv 17(2):460–467
Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-las-Peñas C, Del-Moral-Ávila R, Menjón-Beltrán S, Arroyo-Morales M (2011) Widespread mechanical pain hypersensitivity as a sign of central sensitization after breast cancer surgery: comparison between mastectomy and lumpectomy. Pain Med 12(1):72–78
Hickish T, Astras G, Thomas P, Penfold S, Purandare L, Hickish TF et al (2009) Glucose intolerance during adjuvant chemotherapy for breast cancer. J Natl Cancer Inst. 101(7):537
Sheriff D (2016) Glucose intolerance during adjuvant chemotherapy for breast cancer. J Cancer Prev Curr Res 6(1):102–103
It H (2006) How to manage steroid diabetes in the patient with cancer. J Support Oncol 4:479–483
Buch K, Gunmalm V, Andersson M, Schwarz P, Brøns C (2019) Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism—a systematic review. Cancer Med 8(1):238–245
Klimontov VV, Saik OV, Korbut AI (2021) Glucose variability: how does it work? Int J Mol Sci 22(15):7783
Article CAS PubMed PubMed Central Google Scholar
Tümkaya Yılmaz S, Malfliet A, Elma Ö, Deliens T, Nijs J, Clarys P et al (2022) Diet/nutrition: ready to transition from a cancer recurrence/prevention strategy to a chronic pain management modality for cancer survivors? J Clin Med 11(3):653
Article PubMed PubMed Central Google Scholar
Mantyselka P, Miettola J, Niskanen L, Kumpusalo E (2008) Chronic pain, impaired glucose tolerance and diabetes: a community-based study. Pain 137(1):34–40
Smith AG, Singleton JR (2008) Impaired glucose tolerance and neuropathy. Neurologist 14(1):23–29
Ye D, Fairchild TJ, Vo L, Drummond PD (2023) High blood glucose and excess body fat enhance pain sensitivity and weaken pain inhibition in healthy adults: a single-blind cross-over randomized controlled trial. J Pain 24(1):128–144
Article CAS PubMed Google Scholar
Lu L-j, Wang R-j, Ran L, Gan L, Bai Y, Jin L-b et al (2014) On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test. PloS one. 9(4):e93630
Article PubMed PubMed Central Google Scholar
Jordt N, Kjærgaard KA, Thomsen RW, Borgquist S, Cronin-Fenton D (2023) Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Breast Cancer Res Treat 202:11–22. https://doi.org/10.1007/s10549-023-07043-6
Article PubMed PubMed Central Google Scholar
Zafar MI, Mills KE, Zheng J, Regmi A, Hu SQ, Gou L et al (2019) Low-glycemic index diets as an intervention for diabetes: a systematic review and meta-analysis. Am J Clin Nutr 110(4):891–902
Chiavaroli L, Lee D, Ahmed A, Cheung A, Khan TA, Blanco S et al (2021) Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ (Clinical research ed) 374:n1651. https://doi.org/10.1136/bmj.n1651
Szczuko M, Zapalowska-Chwyć M, Drozd R (2019) A low glycemic index decreases inflammation by increasing the concentration of uric acid and the activity of glutathione peroxidase (GPx3) in patients with polycystic ovary syndrome (PCOS). Molecules (Basel, Switzerland) 24(8):1508
Article CAS PubMed Google Scholar
Zabłocka-Słowińska KA, Skórska K, Płaczkowska S, Prescha A, Pawełczyk K, Kosacka M et al (2019) The relationships between glycemic index and glycemic load of diets and nutritional status and antioxidant/oxidant status in the serum of patients with lung cancer. Adv Clin Exp Med 28(8):1027–1036
Goff L, Cowland D, Hooper L, Frost G (2013) Low glycaemic index diets and blood lipids: a systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 23(1):1–10
Article CAS PubMed Google Scholar
Farvid MS, Tamimi RM, Poole EM, Chen WY, Rosner BA, Willett WC et al (2021) Postdiagnostic dietary glycemic index, glycemic load, dietary insulin index, and insulin load and breast cancer survival. Cancer Epidemiol Biomark Prev 30(2):335–343
Evcili G, Utku U, Ogun M, Özdemir G. (2018) Early and long period follow-up results of low glycemic index diet for migraine prophylaxis. AGRI-the J Turk Soc Algology 30(1). https://doi.org/10.5505/agri.2017.62443
Schröder T, Kühn G, Kordowski A, Jahromi SR, Gendolla A, Evers S et al (2022) A digital health application allowing a personalized low-glycemic nutrition for the prophylaxis of migraine: proof-of-concept data from a retrospective cohort study. J Clin Med 11(4):1117
Article PubMed PubMed Central Google Scholar
Elma Ö, Tümkaya Yılmaz S, Nijs J, Clarys P, Coppieters I, Mertens E et al (2024) Impaired carbohydrate metabolism among women with chronic low back pain and the role of dietary carbohydrates: a randomized controlled cross-over experiment. J Clin Med 13(7):2155
Article CAS PubMed PubMed Central Google Scholar
Corrales PP, Castañeda VB, Ampudia-Blasco F (2020) Update on postprandial hyperglycemia: the pathophysiology, prevalence, consequences and implications of treating diabetes. Revista Clínica Española (English Edition) 220(1):57–68
Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM (2008) Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. The Medscape J Med 10(7):160
Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 1(2):100–107
Article PubMed PubMed Central Google Scholar
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ et al (2012) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 10(1):28–55
Dwan K, Li T, Altman DG, Elbourne DCONSORT (2010) statement: extension to randomised crossover trials. BMJ (Clinical research ed) 2019:366
Julious SA (2005) Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat J Appl Stat Pharm Ind 4(4):287–291
Hertzog MA (2008) Considerations in determining sample size for pilot studies. Res Nurs Health 31(2):180–191
Brown M, Farquhar-Smith P (2017) Pain in cancer survivors; filling in the gaps. Br J Anaesth 119(4):723–736
Comments (0)